|
PTPRG expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.765600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.511500E-02 |
| Normal-vs-Stage2 |
1.926050E-01 |
| Normal-vs-Stage3 |
1.837170E-04 |
| Normal-vs-Stage4 |
4.61870000001419E-06 |
| Stage1-vs-Stage2 |
1.171580E-02 |
| Stage1-vs-Stage3 |
5.65369995264575E-09 |
| Stage1-vs-Stage4 |
2.80349965464666E-10 |
| Stage2-vs-Stage3 |
1.763050E-01 |
| Stage2-vs-Stage4 |
4.206200E-02 |
| Stage3-vs-Stage4 |
3.459000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.151200E-01 |
| Normal-vs-AfricanAmerican |
2.447000E-01 |
| Normal-vs-Asian |
4.162800E-01 |
| Caucasian-vs-AfricanAmerican |
4.271800E-01 |
| Caucasian-vs-Asian |
1.569800E-01 |
| AfricanAmerican-vs-Asian |
1.319840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.481200E-01 |
| Normal-vs-Female |
9.047800E-01 |
| Male-vs-Female |
3.292600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.041000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.900800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.886000E-02 |
| Normal-vs-Age(81-100Yrs) |
1.026340E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.071200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.933800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.142000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.421800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.36179999999675E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.684400E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.962000E-02 |
| Normal-vs-Grade 2 |
9.298600E-03 |
| Normal-vs-Grade 3 |
7.95789999999963E-05 |
| Normal-vs-Grade 4 |
3.4190000000045E-06 |
| Grade 1-vs-Grade 2 |
3.027600E-01 |
| Grade 1-vs-Grade 3 |
7.544800E-03 |
| Grade 1-vs-Grade 4 |
1.63261999999165E-05 |
| Grade 2-vs-Grade 3 |
6.64610033673796E-10 |
| Grade 2-vs-Grade 4 |
3.9324998812873E-10 |
| Grade 3-vs-Grade 4 |
5.859700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.184100E-02 |
| Normal-vs-ccB subtype |
2.624800E-01 |
| ccA subtype-vs-ccB subtype |
5.336300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.057220E-01 |
| Normal-vs-N1 |
1.016790E-01 |
| N0-vs-N1 |
1.873250E-01 |
|
|
